Global Premenstrual Syndrome Treatment Market Share

Market Share of Global Premenstrual Syndrome Treatment Industry

The premenstrual syndrome treatment market is moderately competitive, with several players across the globe. Few big firms currently dominate the market in terms of market share. The companies are raising investment and funding for the development of therapies for the treatment of Premenstrual Syndrome. Bayer AG, Eli Lilly and Company, GlaxoSmithKline Plc, Pfizer Inc., H. Lundbeck A/S are the leading market players with significant market share.

Premenstrual Syndrome Treatment Market Leaders

1. Eli Lilly and Company

2. GlaxoSmithKline Plc

3. H. Lundbeck A/S

4. MetP Pharma AG

5. Bayer AG

*Disclaimer: Major Players sorted in no particular order